STOCK TITAN

Ceragon Networks Reports 2026 First Quarter Financial Results

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Ceragon (NASDAQ: CRNT) reported Q1 2026 revenue of $85.0 million, down 4.1% year-over-year. GAAP gross margin improved to 35.4%, with GAAP operating income of $2.1 million and a GAAP net loss of $1.3 million or ($0.01) per diluted share.

Non-GAAP operating income was $4.2 million, with non-GAAP net income of $0.7 million or $0.01 per diluted share. Cash and equivalents rose to $39.2 million. Revenue was geographically diversified, led by North America (37%) and India (35%). Management reiterated 2026 guidance for revenue of $355–$385 million and higher non-GAAP margins.

Loading...
Loading translation...

AI-generated analysis. Not financial advice.

Positive

  • GAAP gross margin rose to 35.4% from 32.8% year-over-year
  • GAAP operating income improved to $2.1 million from a $1.1 million loss
  • Non-GAAP operating income reached $4.2 million in Q1 2026
  • Shift to non-GAAP net income of $0.7 million and $0.01 EPS
  • Cash and cash equivalents increased to $39.2 million from $38.4 million
  • Management reiterated 2026 revenue guidance of $355–$385 million
  • Non-GAAP operating margin guidance of 6.5%–7.5% for 2026
  • India and North America together contributed 72% of Q1 2026 revenue

Negative

  • Q1 2026 revenue declined 4.1% year-over-year to $85.0 million
  • GAAP net loss widened slightly to $1.3 million from $1.0 million
  • Company highlighted margin pressure risk from cost increases and adverse FX trends

News Market Reaction – CRNT

+0.80%
5 alerts
+0.80% News Effect
+6.1% Peak in 2 hr 1 min
+$2M Valuation Impact
$254.50M Market Cap
0.8x Rel. Volume

On the day this news was published, CRNT gained 0.80%, reflecting a mild positive market reaction. Argus tracked a peak move of +6.1% during that session. Our momentum scanner triggered 5 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $2M to the company's valuation, bringing the market cap to $254.50M at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Q1 2026 revenue: $85.0M Revenue YoY change: -4.1% GAAP operating income: $2.1M +5 more
8 metrics
Q1 2026 revenue $85.0M Quarter ended March 31, 2026; down 4.1% YoY vs Q1 2025
Revenue YoY change -4.1% Q1 2026 vs Q1 2025
GAAP operating income $2.1M Q1 2026
Non-GAAP operating income $4.2M Q1 2026
GAAP net loss $(1.3)M Q1 2026; GAAP EPS $(0.01)
Non-GAAP net income $0.7M Q1 2026; non-GAAP EPS $0.01
Cash & equivalents $39.2M Balance as of March 31, 2026
2026 revenue guidance $355M–$385M Management reiterated full-year 2026 outlook

Market Reality Check

Price: $2.89 Vol: Volume 595,027 is above t...
normal vol
$2.89 Last Close
Volume Volume 595,027 is above the 20-day average of 488,848. normal
Technical Shares at $2.51 are trading above the 200-day MA of $2.26 and about 11.6% below the 52-week high.

Peers on Argus

Peers showed mixed moves, with gains in BKTI (+2.85%) and LTRX (+0.16%), decline...

Peers showed mixed moves, with gains in BKTI (+2.85%) and LTRX (+0.16%), declines in SILC (-12.69%) and INSG (-4.75%), and AUDC flat. With CRNT unchanged pre-news, no clear sector trend is indicated.

Previous Earnings Reports

4 past events · Latest: Feb 17 (Positive)
Same Type Pattern 4 events
Date Event Sentiment Move Catalyst
Feb 17 Q4/FY 2025 earnings Positive -1.8% Q4 and 2025 profitability with reiterated 2026 revenue and margin guidance.
Nov 11 Q3 2025 earnings Neutral +2.6% Revenue decline but solid margins, strong North America and updated 2025 outlook.
Aug 06 Q2 2025 earnings Negative -14.6% Revenue down year-over-year with GAAP loss despite non-GAAP profitability.
May 07 Q1 2025 earnings Neutral -1.8% Flat revenue, operating loss, but strong bookings and maintained 2025 guidance.
Pattern Detected

Recent earnings releases often saw modest negative or volatile reactions, even when guidance and profitability metrics were stable or improving.

Recent Company History

Over the past year, Ceragon’s earnings reports have featured quarterly revenues in the $82–89M range, with gross margins in the mid-30% area and a shift from prior profitability to a $2.1M net loss in 2025. Management repeatedly highlighted North America and India as key growth drivers and has consistently pointed to 2026 as a return-to-growth year, maintaining revenue guidance of $355M–$385M. Today’s Q1 2026 update continues this pattern with solid margins, ongoing India strength, and reiterated full-year guidance.

Historical Comparison

-3.9% avg move · In the past 4 earnings releases, CRNT moved an average of -3.88%. The latest Q1 2026 results continu...
earnings
-3.9%
Average Historical Move earnings

In the past 4 earnings releases, CRNT moved an average of -3.88%. The latest Q1 2026 results continue themes of mid-30% gross margins and reiterated guidance.

Earnings updates from Q1 2025 through Q4/FY 2025 showed revenues stabilizing in the low-to-mid $80M range per quarter, mid-30% gross margins, and a swing from prior profitability to a $2.1M net loss in 2025. Management has consistently emphasized India and North America strength and maintained a $355M–$385M 2026 revenue outlook. The current Q1 2026 report fits this trajectory with slightly lower revenue than Q1 2025 but improved margins and reaffirmed full-year guidance.

Regulatory & Risk Context

Active S-3 Shelf · $250,000,000
Shelf Active
Active S-3 Shelf Registration 2026-05-07
$250,000,000 registered capacity

An effective Form F-3 shelf filed on May 7, 2026 allows Ceragon to issue up to $250,000,000 of ordinary shares, rights, warrants, debt securities, and units over time via future prospectus supplements. No usage has been recorded yet.

Market Pulse Summary

This announcement shows Q1 2026 revenue of $85.0M, down 4.1% year-over-year, but with improved GAAP ...
Analysis

This announcement shows Q1 2026 revenue of $85.0M, down 4.1% year-over-year, but with improved GAAP operating income of $2.1M and non-GAAP net income of $0.7M. Gross margin reached 35.4%, while cash stood at $39.2M. Management reiterated full-year 2026 revenue guidance of $355M–$385M and targeted non-GAAP operating margins of 6.5%–7.5%. Investors may track execution in India and North America, margin resilience amid cost pressures, and any future use of the $250,000,000 Form F-3 shelf.

Key Terms

non-gaap, free cash flow, gross margin, operating margin
4 terms
non-gaap financial
"GAAP Operating income of $2.1 million, non-GAAP operating income of $4.2 million"
Non-GAAP refers to financial measures that companies use to show their earnings or performance without including certain expenses or income that are often added back to give a different picture. It matters because it can make a company's results look better or more favorable, but it may also hide important costs, so investors need to look at both GAAP (official rules) and non-GAAP numbers to get a full understanding.
free cash flow financial
"improved balance sheet with positive free cash flowROSH HA'AIN, Israel"
Free cash flow is the amount of money a company has left over after paying all its expenses and investing in its business, like buying equipment or updating facilities. It shows how much cash is available to reward shareholders, pay down debt, or save for future growth. This helps investors understand if a company is financially healthy and able to grow.
gross margin financial
"GAAP Gross profit was $30.1 million, with a gross margin of 35.4%"
Gross margin is the difference between how much money a company makes from selling its products and how much it costs to produce them, expressed as a percentage of sales. It shows how efficiently a company is turning sales into profit before other expenses like marketing or salaries. Higher gross margin means the company keeps more money from each sale, which is a good sign of financial health.
operating margin financial
"Non-GAAP operating margin 6.5% - 7.5% at the midpoint"
Operating margin shows how much profit a company makes from its core business activities after paying for costs like wages and materials. It’s useful because it tells you how efficiently a company is running—higher margins mean it keeps more money from each dollar of sales, which can indicate better management or stronger products.

AI-generated analysis. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Positive momentum across the business, led by strength in India, and improved balance sheet with positive free cash flow

ROSH HA'AIN, Israel, May 19, 2026 /PRNewswire/ -- Ceragon (NASDAQ: CRNT), a leading solutions provider of end-to-end wireless connectivity, today reported its financial results for the first quarter ended March 31, 2026.

Q1 2026 Financial Highlights:

  • Revenue of $85.0 million, down 4.1% year-over-year
  • GAAP Operating income of $2.1 million, non-GAAP operating income of $4.2 million
  • GAAP Net income (loss) of ($1.3) million, non-GAAP net income of $0.7 million
  • GAAP EPS of ($0.01) per diluted share, non-GAAP EPS of $0.01 per diluted share

Q1 2026 Business Highlights:

  • India – Sequentially higher revenue and strong bookings have increased visibility for remainder of 2026; notable interest in E-band solutions
  • North America – Revenue remained robust; Activity is progressing with new Tier 1 CSP with potential for initial orders starting Q3
  • Private Network – Expanding business with multiple contracts across various customers and use cases

Ceragon's CEO Doron Arazi commented: "Ceragon's first quarter results reflected continued healthy demand across many of our key markets, highlighted by strong activity in India. Our solution offerings, predominantly in E-band frequencies, are driving strong demand in multiple regions. We are also making progress with our FR2 new solution, with a successful POC with a major tier North American carrier and increased interest from other potential customers in North America and Europe. We are also encouraged by the diverse wins we have in the private network domain."

"We are more optimistic with respect to our strategic positioning and the underlying demand environment in our key markets and for our key product cycles, especially given the anticipated changes in the competitive landscape. Several recent macro and industry-wide cost increases and continued adverse foreign currency trends may lead to higher pressure on our margins, especially in the near term, but we are taking actions to minimize these cost challenges. We reiterate our prior 2026 guidance," concluded Arazi.

Primary First Quarter 2026 Financial Results:

Revenues were $85.0 million, down 4.1% from $88.7 million in Q1 2025.

GAAP Gross profit was $30.1 million, with a gross margin of 35.4%, compared to gross margin of 32.8% in Q1 2025.

GAAP Operating income (loss) was $2.1 million compared to ($1.1) million in Q1 2025.

GAAP Net loss, was ($1.3) million, or ($0.01) per diluted share, compared to ($1.0) million, or ($0.01) per diluted share in Q1 2025.

Non-GAAP results were as follows: Gross margin was 36.0%, operating profit was $4.2 million, and net income was $0.7 million, or $0.01 per diluted share.

For a reconciliation of GAAP to non-GAAP results, see the attached tables.

Balance Sheet

Cash and cash equivalents were $39.2 million on March 31, 2026, compared to $38.4 million on December 31, 2025.

Revenue Breakout by Geography:


Q1 2026

North America

37 %

India

35 %

EMEA

15 %

Latin America

7 %

APAC

6 %

Outlook

Management reiterated its 2026 outlook:

  • Revenue of $355 million to $385 million.
  • Non-GAAP gross margin improvement of 100bps at the midpoint of the provided revenue guidance range.
  • Non-GAAP operating margin 6.5% - 7.5% at the midpoint of the provided revenue guidance range.

Conference Call

The Company will hold a Zoom webcast today at 8:30 a.m. ET to review the results, followed by a Q&A session.

Investors are invited to register by clicking here. All relevant access details will be provided upon registration.

For investors unable to join the live call, a replay will be available on the Company's website at www.ceragon.com 

About Ceragon

Ceragon (NASDAQ: CRNT) is the global innovator and leading solutions provider of end-to-end wireless connectivity, specializing in transport, access, and AI-powered managed & professional services. Through our commitment to excellence, we empower customers to elevate operational efficiency and enrich the quality of experience for their end users.  

Our customers include service providers, utilities, public safety organizations, government agencies, energy companies, and more who rely on our wireless expertise and cutting-edge solutions for 5G & 4G broadband wireless connectivity, mission-critical services, and an array of applications that harness our ultra-high reliability and speed. Ceragon solutions are deployed by more than 600 service providers, as well as more than 1,600 private network owners, in more than 130 countries. Through our innovative, end-to-end solutions, covering hardware, software, and managed & professional services, we enable our customers to embrace the future of wireless technology with confidence, shaping the next generation of connectivity and service delivery. Ceragon delivers extremely reliable, fast-to-deploy, high-capacity wireless solutions for a wide range of communication network use cases, optimized to lower TCO through minimal use of spectrum, power, real estate, and labor resources – driving simple, quick, and cost-effective network modernization and positioning Ceragon as a leading solutions provider for the "connectivity everywhere" era. 
For more information please visit: www.ceragon.com

Ceragon Networks® and FibeAir® are registered trademarks of Ceragon Networks Ltd. in the United States and other countries. CERAGON ® is a trademark of Ceragon, registered in various countries. Other names mentioned are owned by their respective holders.

Safe Harbor

This press release contains statements that constitute "forward-looking statements" within the meaning of the Securities Act of 1933, as amended and the Securities Exchange Act of 1934, as amended, and the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on the current beliefs, expectations and assumptions of Ceragon's management about Ceragon's business, financial condition, results of operations, micro and macro market trends and other issues addressed or reflected therein. Examples of forward-looking statements include, but are not limited to, statements regarding: projections of demand, revenues, net income, gross margin, capital expenditures and liquidity, competitive pressures, order timing, supply chain and shipping, components availability; growth prospects, product development, financial resources, cost savings and other financial and market matters. You may identify these and other forward-looking statements by the use of words such as "may", "plans", "anticipates", "believes", "estimates", "targets", "expects", "intends", "potential" or the negative of such terms, or other comparable terminology, although not all forward-looking statements contain these identifying words.

Although we believe that the projections reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations there from will not be material. Such forward-looking statements involve known and unknown risks and uncertainties that may cause Ceragon's future results or performance to differ materially from those anticipated, expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: Company's forward-looking forecasts, with respect to which there is no assurance that such forecasts will materialize; Company's ability to future plan, business, marketing and product strategies on the forecasted evolution of the market developments, such as market and territory trends, future use cases, business concepts, technologies, future demand, and necessary inventory levels; the effects of fluctuations in currency exchange rates between the currencies in which we operate; risks relating to the conversion of the orders from customers into revenues; the effects of global economic trends, including recession, rising inflation, rising interest rates, commodity price increases and fluctuations, commodity shortages and exposure to economic slowdown; risks related to conditions in Israel and the continuation of hostilities in the Middle East; risks associated with delays in the transition to 5G technologies and in the 5G rollout; risks relating to the concentration of our business on a limited number of large mobile operators and the fact that the significant weight of their ordering, compared to the overall ordering by other customers, coupled with inconsistent ordering patterns, could negatively affect us; risks resulting from the volatility in our revenues, margins and working capital needs; disagreements with tax authorities regarding tax positions that we have taken could result in increased tax liabilities; the high volatility in the supply needs of our customers, which from time to time lead to delivery issues and may lead to us being unable to timely fulfil our customer commitments; and such other risks, uncertainties and other factors that could affect our results of operation, as further detailed in Ceragon's most recent Annual Report on Form 20-F, as published on April 15, 2026, as well as other documents that may be subsequently filed by Ceragon from time to time with the Securities and Exchange Commission.

We caution you not to place undue reliance on forward-looking statements, which speak only as of the date hereof. Ceragon does not assume any obligation to update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release unless required by law.

While we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we caution you that these statements are based on a combination of facts and factors currently known by us and our projections on the future, about which we cannot be certain. In addition, any forward-looking statements represent Ceragon's views only as of the date of this press release and should not be relied upon as representing its views as of any subsequent date. Ceragon does not assume any obligation to update any forward-looking statements unless required by law.

The results reported in this press- release are preliminary and unaudited results, and investors should be aware of possible discrepancies between these results and the audited results to be reported, due to various factors.

Ceragon's public filings are available on the Securities and Exchange Commission's website at www.sec.gov and may also be obtained from Ceragon's website at www.ceragon.com.

Investor Contact:

Rob Fink
FNK IR
Tel. 1+646-809-4048
crnt@fnkir.com

Joey Delahoussaye
FNK IR
Tel. 1+312-809-1087
crnt@fnkir.com

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(U.S. dollars in thousands, except share and per share data)


Three months ended
March 31,




2026


2025





Revenues

85,003


88,652

Cost of revenues

54,927


59,553





Gross profit

30,076


29,099





Operating expenses:




Research and development, net

7,941


8,249

Sales and marketing

13,990


12,297

General and administrative

5,520


5,436

Restructuring and related charges

540


3,732

Acquisition- and integration-related charges

-


475





Total operating expenses

27,991


30,189





Operating income (loss)

2,085


(1,090)





Financial and other expenses (income), net

2,856


(990)





Loss before taxes

(771)


(100)





Taxes on income

572


880





Net loss

(1,343)


(980)





Basic net loss per share

(0.01)


(0.01)





Diluted net loss per share

(0.01)


(0.01)





Weighted average number of shares used in computing basic net loss per share

90,709,210


88,742,804





Weighted average number of shares used in computing diluted net loss per share

90,709,210


88,742,804

 

CONDENSED CONSOLIDATED BALANCE SHEETS

(U.S. dollars in thousands)


March 31,


December 31,


2026


2025

ASSETS








CURRENT ASSETS:




Cash and cash equivalents

39,164


38,368

Trade receivables, net

94,421


99,673

Inventories

56,456


61,587

Other accounts receivable and prepaid expenses

23,804


25,576





Total current assets

213,845


225,204





NON-CURRENT ASSETS:




Severance pay and pension fund

378


362

Property and equipment, net

41,852


39,952

Operating lease right-of-use assets

15,715


16,554

Intangible assets, net

23,867


23,182

Goodwill

11,007


11,007

Other non-current assets

690


781





Total non-current assets

93,509


91,838





Total assets

307,354


317,042





LIABILITIES AND SHAREHOLDERS' EQUITY








CURRENT LIABILITIES:




Trade payables

65,576


70,784

Deferred revenues

2,710


2,371

Short-term loans

17,100


19,000

Operating lease liabilities

3,957


4,001

Other accounts payable and accrued expenses

23,167


24,071





Total current liabilities

112,510


120,227





LONG-TERM LIABILITIES:




Accrued severance pay and pension

2,590


2,537

Operating lease liabilities

12,510


13,331

Other long-term payables

8,248


8,195





Total long-term liabilities

23,348


24,063





SHAREHOLDERS' EQUITY:




Share capital

234


234

Additional paid-in capital

455,626


454,640

Treasury shares at cost

(20,091)


(20,091)

Other comprehensive loss

(9,715)


(8,816)

Accumulated deficit

(254,558)


(253,215)





Total shareholders' equity

171,496


172,752





Total liabilities and shareholders' equity

307,354


317,042

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

(U.S. dollars, in thousands)


Three months ended
March 31,


2026


2025





Cash flow from operating activities:




Net loss

(1,343)


(980)

Adjustments to reconcile net loss to net cash provided by operating activities:




Depreciation and amortization

3,434


3,332

Loss from sale of property and equipment, net

70


10

Stock-based compensation expenses

892


650

Decrease in accrued severance pay and pensions, net

37


47

Decrease in trade receivables, net

5,301


6,384

Decrease (increase) in other assets (including other accounts receivable, 
prepaid expenses, other non-current assets, and the effect of exchange rate
changes on cash and cash equivalents)

1,216


(1,140)

Decrease (increase) in inventory

3,830


(2,079)

Decrease in operating lease right-of-use assets

953


731

Decrease in trade payables

(6,174)


(4,084)

Increase (decrease) in other accounts payable and accrued expenses (including other long-term payables)

(1,046)


754

Decrease in operating lease liability

(979)


(825)

Increase (decrease) in deferred revenues

339


(190)

Net cash provided by operating activities

6,530


2,610





Cash flow from investing activities:




Purchases of property and equipment, net

(2,275)


(3,469)

Software development costs capitalized

(1,470)


(538)

Payments made in connection with business acquisitions, net of acquired cash

-


(6,570)

Net cash used in investing activities

(3,745)


(10,577)





Cash flow from financing activities:




Proceeds from exercise of stock options

9


508

Repayments of bank credits and loans, net

(1,900)


-

Net cash provided by (used in) financing activities

(1,891)


508





Effect of exchange rate changes on cash and cash equivalents

(98)


(164)





Increase (decrease) in cash and cash equivalents

796


(7,623)





Cash and cash equivalents at the beginning of the period

38,368


35,311





Cash and cash equivalents at the end of the period

39,164


27,688

 

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL RESULTS

(U.S. dollars in thousands, except share and per share data)


Three months ended
March 31,


2026


2025





GAAP Cost of revenues

54,927


59,553

Stock-based compensation expenses

(131)


(108)

Amortization of acquired intangible assets

(422)


(505)

Non-GAAP Cost of revenues

54,374


58,940





GAAP Gross profit

30,076


29,099

Stock-based compensation expenses

131


108

Amortization of acquired intangible assets

422


505

Non-GAAP Gross profit

30,629


29,712





GAAP Research and development expenses

7,941


8,249

Stock-based compensation expenses

(191)


(155)

Non-GAAP Research and development expenses

7,750


8,094





GAAP Sales and marketing expenses

13,990


12,297

Stock-based compensation expenses

(340)


(310)

Amortization of acquired intangible assets

(220)


(222)

Non-GAAP Sales and marketing expenses

13,430


11,765





GAAP General and administrative expenses

5,520


5,436

Stock-based compensation expenses

(230)


(77)

Non-GAAP General and administrative expenses

5,290


5,359





GAAP Restructuring and related charges

540


3,732

Restructuring and related charges

(540)


(3,732)

Non-GAAP Restructuring and related charges

-


-





GAAP Acquisition- and integration-related charges

-


475

Acquisition- and integration-related charges

-


(475)

Non-GAAP Acquisition- and integration-related charges

-


-





 

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL RESULTS

(U.S. dollars in thousands, except share and per share data)


Three months ended
March 31,


2026


2025





GAAP Operating income (loss)

2,085


(1,090)

Stock-based compensation expenses

892


650

Amortization of acquired intangible assets

642


727

Restructuring and other charges

540


3,732

Acquisition- and integration-related charges

-


475

Non-GAAP Operating income

4,159


4,494





GAAP Financial and other expenses (income), net

2,856


(990)

Leases – financial income

26


95

Non-cash revaluation charges associated with business combination

(9)


1,932

Non-GAAP Financial and other expenses, net

2,873


1,037





GAAP Tax expenses

572


880

Non-GAAP Tax expenses

572


880





GAAP Net income (loss)

(1,343)


(980)

Stock-based compensation expenses

892


650

Amortization of acquired intangible assets

642


727

Restructuring and other charges

540


3,732

Acquisition- and integration-related charges

-


475

Leases – financial income

(26)


(95)

Non-cash revaluation charges associated with business combination

9


(1,932)

Non-GAAP Net income  

714


2,577





GAAP Basic net income (loss) per share

(0.01)


(0.01)





GAAP Diluted net income (loss) per share

(0.01)


(0.01)





Non-GAAP Diluted net income per share

0.01


0.03





Weighted average number of shares used in computing GAAP basic and diluted net income (loss) per share

90,709,210


88,742,804





Weighted average number of shares used in computing Non-GAAP diluted net income per share

92,709,739


91,514,527





Logo - https://mma.prnewswire.com/media/1704355/Ceragon_Networks_Ltd_Logo.jpg

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ceragon-networks-reports-2026-first-quarter-financial-results-302775986.html

SOURCE Ceragon Networks Ltd.

FAQ

How did Ceragon (NASDAQ: CRNT) perform financially in Q1 2026?

Ceragon reported Q1 2026 revenue of $85.0 million and a GAAP net loss of $1.3 million. According to Ceragon, GAAP gross margin improved to 35.4%, GAAP operating income was $2.1 million, and non-GAAP net income reached $0.7 million or $0.01 per diluted share.

Why did Ceragon’s Q1 2026 revenue (CRNT) decline year-over-year?

Ceragon’s Q1 2026 revenue of $85.0 million was down 4.1% from $88.7 million in Q1 2025. According to Ceragon, this decline occurred despite healthy demand in key markets, including strong activity in India and robust revenue in North America.

What are Ceragon’s 2026 revenue and margin expectations for CRNT stock?

Ceragon reaffirmed its 2026 revenue outlook of $355 million to $385 million. According to Ceragon, it also targets non-GAAP gross margin improvement of about 100 basis points and a non-GAAP operating margin range of 6.5% to 7.5% at the midpoint of guidance.

How strong were Ceragon’s regional results in India and North America in Q1 2026?

Ceragon reported strong contributions from India and North America in Q1 2026. According to Ceragon, North America represented 37% of revenue and India 35%, supported by sequentially higher India revenue, strong bookings, and robust North American activity including work with a new Tier 1 CSP.

What does Ceragon’s Q1 2026 balance sheet indicate for CRNT investors?

Ceragon ended Q1 2026 with cash and cash equivalents of $39.2 million. According to Ceragon, this compares with $38.4 million at December 31, 2025, reflecting positive free cash flow and an improved balance sheet alongside ongoing investment in wireless connectivity solutions.

What margin risks did Ceragon highlight with its Q1 2026 CRNT earnings?

Ceragon warned that several macro and industry-wide cost increases and adverse foreign currency trends may pressure margins. According to Ceragon, the company is taking actions to minimize these cost challenges while maintaining its 2026 guidance for improved non-GAAP gross and operating margins.